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2 Fax: +1 501 526 6729.This paper introduces a new dynamical model, called the oscillabolastic model, to analyze the dynamical
behavior of biomedical data when one observes oscillatory behavior. The proposed oscillabolastic model
is sufﬁciently ﬂexible to represent various types of oscillatory behavior. The oscillabolastic model is
applied to two sets of data. The ﬁrst data set deals with the oscillabolastic modeling of Ehrlich ascites
tumor cells and the second one is the oscillabolastic modeling of the mean signal intensity of Hes1 gene
expression in response to serum stimulation. A generalized oscillabolastic model is also suggested to
accommodate cases in which predictor variables other than time are also involved.
 2011 Elsevier Inc. All rights reserved.1. Introduction
Growth and decay models are useful in explaining the time
course of disease progression and regression and their associated
rates. Some growth models may show oscillatory behavior of a
damped or sustained nature, while others may be of a non-
oscillatory nature. For the non-oscillatory case, Tabatabai et al. [1]
introduced three hyperbolastic growth models, which have proven
to be accurate in analysis of many cases of biological growth [1–6].
This paper demonstrates that hyperbolic functions can also be
applied very effectively to assist inmodeling of oscillatory biological
processes. In Section 2,we introduce a newgrowthmodel, called the
oscillabolastic model, capable of modeling damped oscillatory data.
In Section 3, experimental data on the time progression of Ehrlich
ascites tumor cells inmice ismodeledusing this oscillabolasticmod-
el. These results are then compared with the results frommodeling
this data using both the logistic and the damped sinemodels. In Sec-
tion 4 we use the oscillabolastic model to analyze the mean signal
intensity for Hes1 and compare the oscillabolastic model to a
dampedsinusoidalmodel.Generalizationof theoscillabolasticmod-
el to amultivariablemodel is addressed in Section 5, with particular
attention to the case where an increasing drug concentration may
accelerate, decelerate, or otherwise affect the time course of the
oscillations.ll rights reserved.
Tabatabai), weby@cameron.Modeling of oscillatory phenomena has considerable impor-
tance as it occurs in so many real world phenomena. It is especially
relevant in the case of biological systems, where oscillatory behav-
ior is ubiquitous and often serves an important biological purpose,
such as the establishment of regularity in time dependent
processes, i.e. Gore and van Oudenaarden [7]. The mechanisms
underlying the regulation of cellular processes and temporal sig-
naling in cells also rely on oscillatory phenomena. Nelson et al.
[8] argued that oscillations in transcription factors are important
features of cellular signaling pathways. For instance, NF–jB tran-
scription factors play an important role in the control of response
to cellular stress and regulation of cell-cycle and cell growth,
immunity and apoptosis. They claim that the level of the NF–jB
transcription factor follows a damped oscillatory motion over time.
Oscillatory behavior occurs frequently throughout the immune
system; however most cases have not yet been studied. The
perception remains that oscillations in the immune system are pri-
marily associated with pathologies. For example the damped oscil-
lations of the number of erythrocytes infected by the parasites
described in Hoshen et al. [9] lead to the periodic symptoms
observed in malaria patients. However oscillations are important
to the functioning of the immune system in a healthy state. Stark
et al. [10] review some known oscillations in the immune system
and propose a search for a larger theoretical framework to describe
such behavior.
Recently there has been a considerable amount of research
activity investigating effective ways tomodel and understand oscil-
lations in biological systems, from the circadian rhythm to various
ultradian oscillators including the cell cycle, oscillations inherent to
the expression of certain proteins, and the segmentation clock
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opment of vertebrates. Olsen et al. [11] developed an in silicomodel
of cell metabolism during neutrophil activation. Boivin et al. [12]
investigated expression of the genes hPer1, hPer2, hPer3, and
hDec1, which produce oscillations in association with the circadian
clock, and found evidence of their expression in the circulatory
system in human peripheral bloodmononuclear cells. An important
part of the understanding of the biological basis of oscillations is
related to feedback loops, both positive and negative, and Thomas
et al. [13] investigate individual feedback loops and consider the
question of how to ‘‘disentangle’’ a complex network of many feed-
back loops. The paper of Nelson et al. [14] treats the dynamics of
oscillations in transcription factors, in particular the NF–jB path-
way, and focuses on the role of negative feedback in producing
oscillations. The work of Jensen et al. [15] was the ﬁrst to explore
the role of feedback loops in the sustained oscillations observed
in the Hes1 system. Monk [16] has used mathematical modeling
to demonstrate that the oscillations in the expression of the pro-
teins NF–jB, p53, and Hes1 can all be explained using a negative
feedback loop with a time delay due to transcription and transpor-
tation of the proteins. Tiana et al. [17] also discuss the use of a neg-
ative feedback loop in describing the oscillatory behavior in the
protein concentrations NF–jB, p53, and Hes1.
Oscillations in gene expression form one of the fundamental
tools in formation and development of somites in the embryological
development of vertebrates. The Notch signaling pathway coordi-
nates the action of the cells during the formation of somites, and Le-
wis et al. [18] summarize its role in somitogenesis and its role in
coordinating between cells the oscillations produced by the bHLH
transcription regulators, in particular Hes1 and Hes7 in mice. The
oscillation of both Hes1 and Hes7 follows 2 h cycles, following that
of the segmentation clock, and Hirata et al. [19] investigate the role
of the instability and breakdown of the Hes7 protein in establishing
this period of oscillation. Hirata et al. [20] also establish that the
oscillation of Hes1 is based on a negative feedback loop and the ra-
pid degradation of Hes1. Models such as this one conﬁrm the
dependence of Hes1 oscillation on molecular process including
transcription of mRNA, protein transportation, and particularly
the rate of degradation of the Hes1 protein. We introduce in the
next section a simple oscillatory model also capable of representing
such behavior.2. The oscillabolastic growth model
The introduction has given numerous examples of oscillatory
biological behavior for which an oscillatory model would be appro-
priate. However, not many mathematical models are readily avail-
able for this type of behavior. For instance, in modeling left
ventricular isovolumic pressure decay, Langer [21] had to create
an eight-parameter model speciﬁc to the situation of ventricular
pressure. The oscillabolastic model we present in this section
presents an alternative model for scientists modeling damped
oscillatory data. Delay differential equations have been routinely
used to analyze the growth dynamics of many biomedical systems
in the presence of oscillations. On the other hand, delay differential
equations are computationally intensive and almost always re-
quire extensive numerical techniques to approximate their solu-
tion. To avoid using computational intensive delay growth
models, we introduce a new ordinary differential equation called
the oscillabolastic model which has a closed form solution and
can be used to model damped oscillatory biological systems.
Let P(t) represent the size, or magnitude, of a quantity that has a
damped oscillation, given in units of (number), with time t in
units of (time). Note that the speciﬁc units can vary from problem
to problem dependent upon the speciﬁc units in the speciﬁcapplication. The oscillabolastic growth model is an oscillating
model with growth rate given by
dPðtÞ
dt
¼ ch
t
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1þ h2t2
p þM  PðtÞ þ ab cosðbtÞ
t
ð1Þ
for initial condition P(t0) = P0 and t > 0, where a, b, c, and h are mod-
el parameters and M ¼ P0  a sinðbt0Þ=t0  carc sinhðht0Þ=t0.
If t0 ¼ 0; then
M ¼ lim
t!0þ
ðP0  a sinðbtÞ=t  carc sinhðhtÞ=tÞ ¼ P0  ab ch:
The solution of the initial value problem (1) is
PðtÞ ¼ M þ a sinðbtÞ=t þ carc sinhðhtÞ=t ð2Þ
where lim
t!1
PðtÞ ¼ M, and lim
t!0þ
PðtÞ ¼ M þ abþ ch. Recall that molecu-
lar processes such as mRNA transcription, protein transportation,
and Hes1 decay have been shown to affect the form of the oscilla-
tions of Hes1 gene expression. We note that the oscillabolastic mod-
el provides ﬂexibility in the patterns of the oscillations, thus
allowing themodel to represent oscillations in Hes1 signal intensity,
as demonstrated in Section 4. Furthermore, this ﬂexibility allows the
oscillabolastic model to accommodate varying forms of oscillation,
as could arise from modulation in these molecular processes.
The model parameters M, a, b, c, and h can be given a biological
meaning as follows. The equilibrium state of the system, which is
approached as the damped oscillations go to 0, is given by the
parameter M. This has units of (number). To assign a role to the
parameters a, b, c, and h, we must ﬁrst isolate the damped sinusoi-
dal part. The parameter a will represent the original, undamped
magnitude of the sinusoidal oscillation, also with units of (num-
ber). The parameter b has units of 1/(time), and decreasing b
increases the rate of oscillation. The parameters c and h are shape
parameters and jointly affect the overall shape, adjusting the form
of the oscillation. Values of c > 1 and h > 1 stretch the graph
upward. We assume that either ab– 0 or ch– 0; otherwise the
model would reduce to the uninteresting case of P(t) M.
The growth rate dPðtÞdt reaches zero at the time t satisfying the
equation
chﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1þ h2t2
p  carc sinhðhtÞ
t
þ ab cosðbtÞ  a sinðbtÞ
t
¼ 0: ð3Þ
In special cases where c or h is zero, the growth rate reaches
zero at time t such that
tanðbtÞ ¼ bt:
Moreover, if a or b is zero, then the growth rate reaches zero at a
time t satisfying the equation
sinh
htﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1þ h2t2
p
 !
¼ ht:
The sign of the following expression
ch3
ð1þ h2t2Þ3=2
 2ch
t2ð1þ h2t2Þ1=2
þ 2carc sinhðhtÞ
t3
 2ab cosðbtÞ
t2
þ 2a sinðbtÞ
t3
 ab
2 sinðbtÞ
t
; ð4Þ
which describes acceleration of P(t), can be used when analyzing
oscillatory behavior to determine the regions where the function
is accelerating and decelerating. If c or h is zero, the growth function
may have an inﬂection point at time t for which
tanðbtÞ ¼ 2bt
2 ðbtÞ2 : ð5Þ
Table 1
Observed and estimated values for the Ehrlich ascites tumor cell data.
Time Number
of EAT
cells
Oscillabolastic
estimate of the
number of EAT
cells
Logistic
estimate of the
number of EAT
cells
Damped sine
estimate of the
number of EAT
cells
0 4.0 4.00 3.33 4.00
2.0 8.46 9.46 10.87 7.06
3.0 19.9 18.45 18.99 17.84
4.0 31.4 32.5 31.79 33.42
5.0 53.6 50.71 49.91 52.31
6.0 69.2 71.32 72.03 72.79
7.0 91.2 92.23 94.64 93.08
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point at time t such that
sinh
2ht þ 3ðhtÞ3
2ð1þ ðhtÞ2Þ3=2
 !
¼ ht: ð6Þ
The following are the limits of population size P(t) as parame-
ters approach zero:
lim
a!0
PðtÞ ¼ lim
b!0
PðtÞ ¼ M þ carc sinhðhtÞ=t and lim
c!0
PðtÞ
¼ lim
h!0
PðtÞ ¼ M þ a sinðbtÞ=t:
9.0 132.0 127.00 127.95 126.53
11.0 142.0 142.95 142.51 142.46
13.0 130.0 136.52 147.38 137.07
14.0 132.0 126.24 148.34 127.19
15.0 114.0 112.84 148.86 113.75
17.0 81.5 82.59 149.3 81.38
Table 2
Parameter estimates for the Ehrlich ascites tumor using the oscillabolastic model.
Parameter Estimate Std. error 95% Conﬁdence interval
Lower bound Upper bound
a 527.980 52.492 646.726 409.235
b .365 .011 .342 .389
c 712.252 335.674 47.095 1471.598
h .301 .063 .158 .444
Table 3
Parameter estimates for the Ehrlich ascites tumor using the damped sine model.
Parameter Estimate Std. error 95% Conﬁdence interval
Lower bound Upper bound
a 79.445 6.294 93.684 65.205
b .293 .008 .310 .275
c 1.862 .092 1.653 2.070
h .020 .013 .009 .050
solid: number of cells
dashed: growth rate 
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Fig. 1. Graph of the number of Ehrlich ascites tumor cells function and its rate
function using the oscillabolastic model.3. Analysis of Ehrlich ascites tumor cells
Krug and Taubert [22] used the logistic equation to model the
growth of Ehrlich ascites tumor (EAT) in a mouse from the patho-
logical institute of the Leipzig University. Schuster and Schuster
[23] used a delay logistic growth model to analyze the EAT data.
In this section the EAT data is ﬁt with the proposed oscillabolastic
growth model. To analyze the oscillations of EAT, both the oscillab-
olastic model (2) and a damped sine model of the form
PðtÞ ¼ M þ a sinðbt þ cÞExpðhtÞ ð7Þ
is ﬁtted to the EAT data. For this damped sine model, the parameter
a is the initial amplitude of oscillation, b2p
  is the frequency, h is the
decay parameter, c is the phase parameter and M is deﬁned as
M ¼ P0  a sinðbt0 þ cÞExpðht0Þ
where P0 = P(t0). The mean of the absolute relative errors using the
oscillabolastic growth model is 0.0372 with a standard deviation of
0.03253 and the associated mean for Ehrlich ascites tumor data
using a logistic model is 0.1606 with a standard deviation of
0.22432. In comparison the mean of the absolute relative errors
for the logistic model is over four times the oscillabolastic model.
The mean of the absolute relative errors for the damped sine model
is 0.0437 with a standard deviation of 0.0439. Table 1 gives the
observed and estimated values for Ehrlich ascites tumor cell data
using oscillabolastic, logistic and damped sine growth models.
Parameter estimates for oscillabolastic and damped sine models
are given in Tables 2 and 3 respectively. The R-squared for both
oscillabolastic and damped sine models is 0.996 and the Residual
Mean Squares for oscillabolastic and damped sine models are
13.486 and 14.594 respectively.
By analyzing Fig. 1, which is the graph of the oscillabolastic
growth model P(t), and its associated growth rate dPðtÞdt for the
Ehrlich ascites data, we ﬁnd out that the number of EAT cells in-
creases from the start which is the time t = 0 until it reaches its
maximum number at the time t = 11.3979 days. At this point this
maximum number of Ehrlich ascites tumor cells is 1.43401 
109. The growth rate of the number of Ehrlich ascites tumor cells
increases from the start where t = 0 until it reaches its maximum
at time t = 6.13933 days. At this time the growth rate is
2.11382  108 cells per day. In addition, the growth of the number
of Ehrlich ascites tumor cells speeds up from the starting time t = 0
until reaching time t = 6.13933 days. During this time period both
the growth rate dPðtÞdt and its rate of change
d2PðtÞ
dt2
are positive. After
we pass time t = 6.13933, the growth rate dPðtÞdt starts to decline until
reaching a minimum growth rate of 1.53782  108 cells per day,
occurring at time t = 16.0853 days. In Fig. 2, we use the damped
sine model to predict the number of Ehrlich ascites tumor cells
and its rate of change with respect to time.
Figs. 3–5 depict the graphs of the number of observed and pre-
dicted Ehrlich ascites tumor cells using oscillabolastic, logistic, and
damped sine models, respectively.4. Analysis of mean signal intensity for Hes1
As mentioned in the Introduction, the expression of the gene
known as Hes1 is a highly interesting area of active current re-
search. Due to the negative feedback loop in the production of
Hes1 mRNA and Hes1 protein from the gene, the level of expres-
sion of Hes1 experiences oscillations, and it is important to have
a good understanding of the time course of such oscillation. Using
experimental data describing the mean signal intensity of Hes1, we
solid: number of cells
dashed: growth rate
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cell cell rate
Fig. 2. Graph of the number of Ehrlich ascites tumor cells function and its rate
function using the damped sine model.
Dashed: data points
Solid: oscillabolastic estimation
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Fig. 3. Line graph of an observed and estimated number of Ehrlich ascites tumor
cells using the oscillabolastic growth model.
Dashed: data points
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Fig. 4. Line graph of an observed and estimated number of Ehrlich ascites tumor
cells using the logistic growth model.
Dashed: data points
Solid: damped sine estimation
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Fig. 5. Line graph of an observed and estimated number of Ehrlich ascites tumor
cells using the damped sine growth model.
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oscillations very well, the oscillabolastic model provides a much
better ﬁt. The high level of interest and research in Hes1 is well
deserved as it is shown to be a key player in important areas such
as neurogenesis, morphoenesis, myogenesis, regulation of expres-
sion of various genes within the Notch pathway, cellular differen-
tiation and proliferation, and suppression of tumors in human
breast cancer. In relation to its role in embryonic development,
the oscillations of the gene expression in time are believed to carry
over to pattern formation in space as the cells develop, Pourquié
[24]. The potential for advances on both the theoretical side and
clinical side, related to this stream of research, is signiﬁcant.
The role of Hes1 in somite formation begins in the presomitic
mesoderm (PSM), before the initiation of somitogenesis, as ob-
served in Lewis et al. [18], where Hes1 and Hes7 are among the
genes that were the ﬁrst genes discovered oscillating within the
presomitic mesoderm. Pourquié and Goldbeter [25] discuss the
role of recent mathematical models representing the segmentation
clock and give an indication of the importance of developing math-
ematical models in genetic regulatory networks. Ohtsuka et al. [26]
investigated the precise role of Hes1 and Hes5 in maintenance of
undifferentiated embryonic telencephalic stem cells, which devel-
op into neurons and astroglia later in embryonic development. The
molecular basis for differentiation from granule neuron precursors
within the cerebellar cortex is investigated by Solecki et al. [27],
and Hes1 plays a role in the proliferation of these precursors, with-
in the Notch pathway. In a recent paper Kobayashi and Kageyama
[28] explored the role of Hes1 oscillation in activation and
inactivation of Notch signaling, also as related to differentiation
of murine embryonic stem cells. Low levels versus high levels of
Hes1 are associated with the tendency to differentiate into neuralcells versus mesodermal cells. Another paper by Kobayashi et al.
[29] found that Hes1 oscillation in embryonic stem cells leads to
oscillation in the downstream genes, including the gene Dll1,
inducing differentiation within the Notch pathway, and the gene
Gadd45 g, which inhibits cell cycle progression.
As a basic helix-loop-helix transcriptional regulator, Hes1 plays
an important role in the analysis of cell differentiation and prolif-
eration, as observed in Murata et al. [30], who also displayed
experimental results showing the impact on thymic T-cell progen-
itors of mice who were genetically Hes1/. The absence of Hes1
may adversely affect the development of many tissues in the body.
Kunisato et al. [31] have demonstrated that the Hes1 gene can pre-
serve hematopoietic stem cells ex vivo derived from a bone marrow
KSL population. These authors believe Hes1 gene may function as a
regulator in the process of self-renewal of hematopoietic stem
cells. This function is comparable to the known role of Hes1 in
self-renewal of neuronal stem cells [26]. Georgia et al. [32] estab-
lished the role of p57 and Hes1 in regulation and self-renewal of
the pancreas progenitor cells at an early stage of organogenesis. Fi-
nally, in its regulation of cellular differentiation and proliferation
Hes1 also plays a role in formation of critical tissues within organs,
for instance the study of Francesca et al. [33] which demonstrated
the role of Hes1 in proper formation of the outﬂow tract within the
heart in experimental mice.
Hes1 is important in the development of many types of progen-
itor cells, as well as regulating their later differentiation. The work
of Murata et al. [30] has already been cited as evidence of the im-
pact of Hes1 in the development of thymic T cell progenitors, and
there have been a number of other studies which implicate Hes1 in
development of precursors for T cells. For instance the study of Kim
Table 4
Oscillabolastic parameter estimates for the analysis of Hes1 data.
Parameter Estimate Std. error 95% Conﬁdence interval
Lower bound Upper bound
a 2.700 .310 3.459 1.940
b 3.632 .075 3.448 3.816
c 3.413 .709 1.679 5.147
h 3.275 .782 1.360 5.189
Table 5
Damped sine parameter estimates for the analysis of Hes1 data.
Parameter Estimate Std. error 95% Conﬁdence interval
Lower bound Upper bound
a 3.030 .740 4.840 1.219
b 3.083 .234 3.657 2.510
c 1.958 .469 .810 3.107
h .219 .172 .202 .640
solid: intensity of Hes1
dashed: rate of change of intensity
1 2 3 4
hours
10
5
5
10
intensity intensity rate
Fig. 7. Estimated graph of mean signal intensity and its rate for Hes1 using the
oscillabolastic model.
Table 6
Observed and estimated values for the mean signal intensity Hes1 data.
Time Observed mean
signal intensity
Hes1
Oscillabolastic estimate
of mean signal intensity
Hes1
Damped sine estimate
of mean signal
intensity Hes1
0 1.00 1.00 1.00
0.5 2.99 3.05 2.71
1.0 7.75 7.39 6.00
1.5 5.74 6.19 4.8
2 2.74 2.91 2.09
2.5 3.11 3.09 2.02
3 4.1 3.92 5.13
3.5 2.94 2.57 4.59
4 2.17 1.79 2.78
4.5 1.91 2.55 3.12
 Dashed: data points
 Solid: oscillabolastic estimate
1 2 3 4
Time hours
2
4
6
Intensity
Fig. 6. Line graph of an observed and estimated number of mean signal intensity
Hes1 using the oscillabolastic growth model.
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the CD4 silencer in control of CDr gene expression, a pathway
affecting T cell development.
From the above discussion, Hes1 is clearly important in both
health and disease. It also plays a role in controlling cancer through
its regulatory role in cell proliferation. Strom et al. [35] pointed out
a potential role of Hes1 as a suppressor of tumor development in
epithelial cells, and as a mediator of 17b-estradiols proliferative ef-
fect on the cancer of breast cells. They believe that Hes1 works as a
regulator of differentiation as well as a determinant of cellular pro-
liferation rate. The dissertation of Müller [36] presents joint work
with a number of authors in a series of papers on the relation of
Hes1 gene expression to all-trans-retinoic acid, 17 b-estradiol,
and the impact on human breast cancer cells. Liu et al. [37] studied
Hes1 and Hes5 in relation to squamous cervical carcinomas and
found signiﬁcantly higher levels of expression of Hes1 and Hes5
in squamous cervical carcinomas as compared to normal cervical
epithelia. The authors suggest a role for Hes1 and Hes5 in carcino-
genesis and in progression of the tumor and consider use of Hes1
and Hes5 for prognosis of patients. Yoshiura et al. [38] analyzed
temporal changes in gene expression after serum stimulation. They
studied the dynamics of regulatory networks and the effects of
Hes1 oscillations on the efﬁciency of cell proliferation.
To analyze the oscillations of the mean signal intensity of Hes1
gene expression, both the oscillabolastic model and a damped sine
model are ﬁtted to the Hes1 data. The parameter estimates forHes1 data using oscillabolastic and damped sine models are shown
in Tables 4 and 5, respectively. These data show that damped sine
does not ﬁt the data well. However the oscillabolastic model does.
Because of the close ﬁt of the data, the model can be used to predict
the level of Hes1 mean signal intensity with accuracy. Figs. 7 and 9
show the graphs of estimated mean signal intensity and its rate of
change, for the oscillabolastic and damped sine models, respec-
tively. It can furthermore allow us to describe the time periods
during which Hes1 signal intensity increased and decreased, as
well as the local maxima and minima, information not revealed di-
rectly by the data itself. By analyzing the oscillabolastic model ﬁt
to this Hes1 data, we realize that the mean signal intensity in-
creases (progresses) on the time intervals (0, 1.14), (2.20, 2.94),
and (3.93, 4.5) and regresses (decreases) on the intervals (1.14,
2.20), (2.94, 3.93). For this data, the oscillabolastic result shows
that during the time intervals of (0, 0.623), (2.20, 2.55), and
(3.93, 4.29), the mean signal intensity progression speeds up. On
the other hand, the mean signal intensity progression slows down
on the time intervals (0.623, 1.14), (2.55, 2.94), and (4.294, 4.50).
The regression of the mean signal intensity speeds up on the inter-
vals (1.14, 1.62) and (2.94, 3.41) and slows down on the intervals
(1.62, 2.20) and (3.41, 3.93). The signal intensity reaches its maxi-
mum of 7.69205 at the time t = 1.1442 h. It reaches its ﬁrst local
minimum of 2.55927 at the time t = 2.20174 h. The second local
maximum signal intensity of 3.9382 occurs at the time
t = 2.93727 h and the second local minimum signal intensity is
1.77031, which happens at the time t = 3.9283 h. The period of
oscillation is about 2 h.
The oscillabolastic provides a much better ﬁt to the data. The
oscillabolastic R-squared value is 0.97 which is very much higher
than the R-squared value of 0.714 for the rival damped sine model.
The residual mean square error for the damped sine model is 1.682
which is more than nine times the residual mean square error
value of 0.179 for the oscillabolastic model. The mean absolute
Dashed: data points
Solid: damped sine estimate
1 2 3 4
Time hours
2
4
6
Intensity
Fig. 8. Line graph of an observed and estimated number of Hes1 using the damped
sine model.
solid: intensity of Hes1
dashed: rate of change of intensity
1 2 3 4
hours
10
5
5
10
intensity intensityrate
Fig. 9. Estimated graph of mean signal intensity and its rate for Hes1 using the
damped sine model.
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three times as large as the mean absolute relative error of 0.0892
for the oscillabolastic model. Table 6 gives the observed and esti-
mated values for the mean signal intensity using both oscillabolas-
tic and damped sine models. Figs. 6 and 8 are the line graphs of
observed and predicted values for Hes1 mean signal intensity
using the oscillabolastic and damped sine models, respectively.5. Generalized oscillabolastic model
In this section we generalize the oscillabolastic model to accom-
modate the case when one has multiple predictors and wants to
analyze the effects of these predictors in predicting the population
size. Evidence suggests that in many cases the complex biomedical
growth dynamics of population size P may depend not only on a
single variable such as time but also on a set of explanatory vari-
ables which may affect the growth in a variety of ways, such as
acceleration or deceleration of the growth dynamics. Xiao et al.
[39] demonstrated that factors such as immune response,
pathogen-induced mortality, recovery, and pathogen removal can
induce damped oscillations in the infection dynamics of various
Salmonella serotypes. Bernard et al. [40] performed a mathematical
simulation of the effect of the Groucho (GRO) gene in Drosophila or
one of its counterpart in vertebrates, the transducine-like enhancer
of split (TLE1), in regulating Hes1 transcription. The GRO is also a
member of the Enhancer of split complex, and each of GRO and
TLE1-4 functions as a corepressor of Hes1 by forming a complex
within the nuclear matrix, as demonstrated in the work of McLar-
ren et al. [41]. This study of McLarren et al. also implicates another
player in Hes1 expression, as the RUNX protein is shown to inhibit
this repression of Hes1 expression by the GRO/TLE1 complex. Thusthe work of Bernard et al. [40] and McLarren et al. [41] illustrate
that the level of GRO/TLE1 and the level of RUNX in the system
form additional variables that can affect the oscillations. Sung
and Simon [42] studied the in silico simulation of inhibitor drug
effects on the transcription factor family – jB pathway dynamics.
Such a dynamical model will help the development of treatments
for molecularly targeted therapy. Therefore there is a need to mea-
sure the population growth while allowing for the effects of
explanatory variables. Let X be a k-dimensional vector of explana-
tory variables and k be a vector of parameters. We deﬁne the
growth function P of the vector X as the k-variate oscillabolastic
growth model if P takes the functional form
PðX;a; b; h; c; kÞ ¼ M þ a sinðbgðX; kÞÞ=gðX; kÞ
þ carc sinhðhgðX; kÞÞ=gðX; kÞ ð8Þ
where M¼P0asinðbgðX0;kÞÞ=gðX0;kÞcarcsinhðhgðX0;kÞÞ=gðX0;kÞ
and P0¼PðX0;a;b;h;c;kÞ where X0 is the vector of explanatory
variables at time t0. The function g(X; k) is a link function whose
functional form depends on the nature of the problem under study.
The rate of growth of the population size PðX;a;b;h;c;kÞ with respect
to variable Xi is given by
@PðX;a; b; h; c; kÞ
@Xi
¼ ch
t
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1þ h2gðX; kÞ2
q
þM  PðX;a;b; h; c; kÞ þ abcosðbgðX; kÞÞ
gðX; kÞ
 @gðX; kÞ
@Xi
where i ¼ 1;2; . . . ; k: ð9Þ
If k = 1 and g(X; k) = t is then the model (8) reduces to the oscil-
labolastic growth model (2).
The choice of g(X; k) depends on the nature of the study and has
to be decided by the investigator. If the effect of explanatory vari-
ables is to accelerate or decelerate the time course, then one may
use a link function of the form gðX; kÞ ¼ X1e
Pk
i¼2kiXi or a link func-
tion of the form gðX; kÞ ¼ e
Pk
i¼1kiXi where the variable X1 represents
the time t.
6. Discussion
In this paper we have introduced the oscillabolastic model to
analyze the dynamics of data when damped oscillations are ob-
served. The model is ﬂexible to ﬁt experimental data. It has an
advantage over the ordinary damped sine model of the form (3)
in a sense that it can also handle the situations where the damped
data is oscillating and increasing or oscillating and decreasing. For
the analysis of Ehrlich ascites tumor cells growth, both the oscil-
labolastic and the damped sine models performed well in ﬁtting
the experimental data, but the oscillabolastic model did perform
best. The ﬁt using the logistic growth model was totally unaccept-
able. For the analysis of Hes1 signal intensity data, the oscillabolas-
tic model outperformed the damped sine model in all three
measures of goodness of ﬁt. The R-squared for the oscillabolastic
model was 0.97 compared to 0.714 for the damped sine data.
The residual mean square error for the damped sine model was
more than nine times the corresponding residual mean square er-
ror for the oscillabolastic model. Finally the mean absolute relative
error for the damped sine model was about three times the corre-
sponding number for the oscillabolastic model. Overall, we believe
that for both data sets under consideration, the oscillabolastic
model is a better ﬁt and should be considered by scientists and
practitioners as a powerful tool in modeling oscillatory experimen-
tal data. Whether this model would produce the best ﬁt in other
data sets should be tested and applied in future studies. The results
presented in this paper indicate that the oscillabolastic model has
M.A. Tabatabai et al. / Journal of Biomedical Informatics 45 (2012) 401–407 407the potential to signiﬁcantly improve the ﬁt if the damped sine
model fails to represent the data well. This increased accuracy is
due to the ﬂexibility of the oscillabolastic growth curve.
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